111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Analyze analyst forecasts for the company and compare them with competitors.
38.39B
The estimated revenue has increased from the previous period.
6.05B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
3.97B
The estimated net income has increased from the previous period.
3.91B
The estimated EBIT has increased from the previous period.
8.60B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
54.94B
Revenue has decreased from the previous period.
6.63%
Revenue growth rate has decreased from the previous period.
9.11B
EBITDA has increased from the previous period.
16.58%
EBITDA margin has increased from the previous period.
6.28B
EBIT has increased from the previous period.
11.44%
EBIT margin has increased from the previous period.
2.82B
Depreciation has decreased from the previous period.
10.31B
Total cash has decreased from the previous period.
18.77%
Cash percentage has decreased from the previous period.
4.35B
Receivables have increased from the previous period.
7.92%
Receivables percentage has increased from the previous period.
6.75B
Inventories have increased from the previous period.
12.28%
Inventory percentage has increased from the previous period.
4.79B
Accounts payable has increased from the previous period.
8.73%
Payables percentage has increased from the previous period.
-2.83B
Capital expenditure has increased from the previous period.
-5.15%
CapEx percentage has increased from the previous period.
8.64%
WACC has decreased from the previous period.
10.12%
Cost of equity has decreased from the previous period.
4.08%
Cost of debt has decreased from the previous period.
1.28
Beta has decreased from the previous period.
689.50M
Diluted shares outstanding has decreased from the previous period.
17.15B
Total debt has increased from the previous period.
64.88B
Total equity has decreased from the previous period.
82.03B
Total capital has increased from the previous period.
20.91%
Debt weighting has increased from the previous period.
79.09%
Equity weighting has decreased from the previous period.
4.73B
EBIAT has increased from the previous period.
4.34B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
66.61B
Terminal value has increased from the previous period.
61.24B
Enterprise value has increased from the previous period.
12.98B
Net debt has increased from the previous period.
48.26B
Equity value has increased from the previous period.
69.99
Equity value per share has increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
